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HEALTH CARE AND DRUG UTILIZATION PATTERNS IN
PATIENTS RECEIVING LONG TERM THIENOPYRIDINE
THERAPY
McCollam PL1, Lage M2, Bowman L1
1Eli Lilly and Company, Indianapolis, IN, USA; 2HealthMetrics
Outcomes Research, Groton, CT, USA
OBJECTIVES: Long-term antiplatelet therapy is typically con-
sidered standard of care for secondary prevention of cardiac
events. The goal of this study was to examine patterns of use
and total health care utilization in patients receiving clopidogrel.
METHODS: The study used a random subset of the Pharmet-
rics Patient-Centric Database (2001–2002) representing 3
million commercially insured members. Inclusion criteria were:
index prescription for clopidogrel preceded by a 3-month drug
free pre-period, followed by a 6-month post-period. RESULTS:
Of 11,000 patients included; mean age was 63.7, 58% were
male, 74% were Health Maintenance Organization members.
Common comorbidities included: diabetes 24%, myocardial
infarction 16%, acute coronary syndrome 18%, angina 18%,
coronary heart disease 57%, stroke/transient ischemic attack
24%. Pre-period resource utilization showed 33% had an 
Emergency Room (ER) encounter, 58% were hospitalized, 58%
had a cardiologist encounter, 38% a general practitioner (GP)
encounter. Mean total charges were $25,807. Percutaneous coro-
nary intervention (PCI) was also common (38.6%). In the post-
period, 24% had an ER encounter, 54% were hospitalized, 44%
had a cardiologist encounter, 63% a GP encounter. Mean total
charges were $17,357. PCI occurred in 8.4% during the post-
period. Sixty-seven percent of patients received the index clopi-
dogrel prescription within 7 days of an ER encounter. Mean
length of clopidogrel therapy was 86 days. Patterns of use
showed 67% Stopped (not on clopidogrel 28-days prior to end
of follow-up), 82% with a Gap (reﬁlls were > 14 days apart).
Concomitant statin use occurred in 57% (atorvastatin 32%).
CONCLUSIONS: As deﬁned by an index prescription, substan-
tial resources were used both pre and post-period and coronary
intervention was common. Long-term adherence to clopidogrel
was poor and did not meet current guidelines. Patients receiving
clopidogrel had many comorbidities and were high utilizers of
health care resources, suggesting the need for better guideline
compliance and perhaps better treatments.
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7309 HEALTH CARE RESOURCE UTILIZATION BY PATIENTS
WITH ESSENTIAL HYPERTENSION
Nair RR, Bollu VK, Blake SG
The University of Louisiana at Monroe, Monroe, LA, USA
OBJECTIVE: About 30% of US adult population suffers from
hypertension and this rate is expected to increase in coming
years. This study examined current therapeutic choices associ-
ated with treatment of essential hypertension. Hypertensive
related and total health care resource utilization were also exam-
ined. METHODS: Data from 2000 Medical Expenditure Panel
Survey were retrospectively analyzed. Patients were identiﬁed by
the ICD-9 CM code “401”, who were above 17 years of age and
were not pregnant. All patients who received an anti-hyperten-
sive also had a diagnosis of essential hypertension. Health care
resource utilization was measured from ER, inpatient, physician,
and prescription medicine expenses. RESULTS: A total of 2894
patients were identiﬁed as diagnosed with essential hypertension.
Patients in the study group were predominantly female (58%),
caucasians (78%), and over 50 years of age (75%). Angiotensin
Converting Enzyme inhibitors (ACE) and Calcium Channel
Blockers (CCB) formed the major treatment choices for essential
hypertension. The choice of treatment strategy differed with
patient’s type of insurance. Only 25% of study group rated their
general health as excellent or very good (SF–12). About 8% of
the study population had at least one episode of stroke. Total
health care expenses for the study group exceeded $15 million.
The mean total health care expense for a single hypertensive
patient was above $5000. Prescription anti-hypertensives were
23% of the total health care expenses. Physician and ER visits
were found to be the major cost categories for the hypertension
patients. CONCLUSIONS: Health care resource utilization by
hypertensive patients is expected to increase with the increase in
the number of patients. CCBs and ACE inhibitors formed the
treatment of choice for hypertension treatment. Prescription
medicine expenses formed only a small percentage of the total
health care expense.
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TOBACCO COST-EFFECTIVENESS ANALYSES AND THE PAYER:
IS THE SHORT TERM LONG OVERDUE?
Reed KE,Wieck SG, Tengs TO
Milliman USA, Denver, CO, USA
OBJECTIVE: Despite overwhelming evidence that tobacco ces-
sation interventions are cost-effective, only 24% of employer-
sponsored health plans offer any coverage for tobacco-use
treatment. One reason may be that health plans fear that they
won’t recoup projected savings because of member turnover,
which averages 10–20% annually. The objective of this study
was to assess whether the cost-effectiveness literature provides
health plans with the information they need to make tobacco
treatment coverage decisions. METHODS: We performed a com-
prehensive search for all cost-effectiveness analyses of tobacco
cessation interventions published in 1980 or later. Two readers
independently reviewed 23 analyses and recorded several items
including: 1) the perspective of the analysis; 2) whether medical
cost savings were assessed; 3) the time-frame over which the
medical costs were calculated; and 4) whether comprehensive
program implementation costs were included. RESULTS: Of the
23 analyses reviewed, 13 described the cost-effectiveness of
potentially reimbursable services or medications from the payer’s
perspective. However, of the 13, only two incorporated medical
cost offsets from smoking cessation. Neither described the cost
implications over the short term nor did they include the
program costs that are of interest to payers. CONCLUSIONS:
Published cost-effectiveness information for tobacco treatments
is not presented in a way that is useful to health plans. Provid-
ing information in a manner more useful to managed care orga-
nizations, emphasizing short term cost savings, could lead to
better coverage of tobacco treatment.
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MEDICARE EXPENDITURES IN RELATION TO FUNCTIONAL
HEALTH STATUS POST-STROKE FOR A NATIONALLY-
REPRESENTATIVE SAMPLE OF MEDICARE BENEFICIARIES
FROM 1996 TO 2000
Singhal PK, Stuart B, Menis M, Kamal-Bahl S
University of Maryland, Baltimore, MD, USA
OBJECTIVES: 1) Using Medicare Current Beneﬁciary Survey
(MCBS) develop a retrospective cohort of Medicare beneﬁciaries
with incident stroke; and 2) determine Medicare expenditures in
relation to health status and time since stroke. METHODS: We
used longitudinal MCBS surveys linked to Medicare claims from
1996 to 2000. The MCBS reports data from in-home interviews
on a nationally-representative sample of approximately 17,000
Medicare beneﬁciaries each year. It contains detailed information
on beneﬁciaries’ socio-demographic characteristics and general
